OTC · Drug Manufacturers - Specialty & Generic

NeutriSci International Inc. (NRXCF) Stock

$0.00 OTC: NRXCF Healthcare

NeutriSci International Inc. is a company that operates globally, focusing on the creation, promotion, and supply of nutraceutical products across Canada, the United States, Europe, Asia, and South America.

Valuation

MetricValue
Price$0.00
Market Cap$653980
P/E Ratio-1.09
P/B Ratio-1.35
P/S Ratio1.95
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE100.00%
ROA-232.63%
ROCE123.88%
Gross Margin-9.48%
Operating Margin-150.74%
Net Margin-168.43%
Debt/Equity0.00
Current Ratio0.22

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-2.0M$-2.0M$-2.0M$-1.0M
Net Profit$-2.0M$-2.0M$-2.0M$-2.0M$-1.0M
EPS$-0.02$-0.01$-0.01$-0.01$0.00
Op Margin-2733.8%-1710.7%-2607.2%-1857.6%-150.8%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$1.0M$1.0M$1.0M$1.0M$0
Total Liabilities$0$1.0M$1.0M$1.0M$1.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Latest News

Nvidia (NVDA) Teams Up With Kawasaki To Build AI Powered Shipyard Robots Simply Wall St. · Aug 2, 2026 Quilter (LSE:QLT) Stock Fair Value Edges Higher As Analysts Rework Margin Assumptions Simply Wall St. · Aug 2, 2026 Lear (LEA) Files Shelf Registrations Covering 1,725,000 ESOP Shares And Future Funding Simply Wall St. · Aug 2, 2026 CNA Financial (CNA) Q2 Earnings Report Preview: What To Look For StockStory · Aug 2, 2026 JBT Marel (JBTM) Reports Q2: Everything You Need To Know Ahead Of Earnings StockStory · Aug 2, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-2.0M$-1.0M$-2.0M$-1.0M$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$0$0$1.0M$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-2.0M$-1.0M$-2.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-1.37
FCF Yield-19.15%
Quick Ratio0.21
Interest Coverage0.00
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ELLXFElixinol Wellness Limited $0.01 +0.00% -0.28 $1.63M 0.00%
IDCNIndocan Resources Inc. $0.00 $74079 0.00%
MSMYMC Endeavors, Inc. $0.00 -19.76 $364075 0.00%
NPHCNutra Pharma Corp. $0.00 -1.00 $2.15M 0.00%
PHCGPure Harvest Corporate Group, Inc. $0.02 -6.84% 0.46 $3.18M 0.00%

About NeutriSci International Inc.

NeutriSci International Inc. is a company that operates globally, focusing on the creation, promotion, and supply of nutraceutical products across Canada, the United States, Europe, Asia, and South America. Among its notable offerings is "neuenergy," an energy-boosting tablet specifically designed to enhance concentration and mental sharpness. The company makes its products accessible to consumers through an extensive distribution network that includes both traditional brick-and-mortar retail stores and various online sales channels. Furthermore, NeutriSci International Inc. maintains strategic collaborations with partners such as LaSanta Botanicals, Nutritional High, and Naturally Splendid. The firm was established in 2009, and its corporate headquarters are located in Vancouver, Canada.

NeutriSci International Inc. (NRXCF) stock trades at $0.00 with a market capitalization of $653980. The stock is valued at a price-to-earnings (P/E) ratio of -1.09, price-to-book of -1.35, price-to-sales of 1.95. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, NeutriSci International Inc. generates a return on equity (ROE) of 100.00% — well above the market average, a sign of a high-quality business, return on capital employed of 123.88%, an operating margin of -150.74%, a net profit margin of -168.43%.

Official website: www.neutrisci.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides